publication . Preprint . Other literature type . 2020

COVID-19 Persistent: TREATMENT WITH IVERMECTIN AND ACETYLSALICYLIC ACID OF PATIENTS WITH THE PERSISTENT SYMPTOM OF ANOSMIA OR HYPOSMIA.

Chang, Gustavo Aguirre; Saavedra, Eduardo Castillo; Cerna, Manuel Yui; Figueredo, Aurora Natividad Trujillo;
Open Access English
  • Published: 26 Sep 2020
Abstract
INTRODUCTION: Anosmia and Hyposmia, which is the loss or decrease of smell, is a symptom that occurs in 30 to 70% of patients with COVID-19 in its acute stage, but it also occurs frequently within the symptoms that persist for weeks after the acute stage of the disease. There is no consensus regarding a specific and effective treatment for this persistent symptom, and there is a lack of knowledge of its pathophysiology and the factors related to its persistence. Based on the previous experiences by our work team, regarding the use of drugs to reduce the load and viral replication for the treatment of persistent symptoms of COVID-19, we carried out new studies wi...
Subjects
free text keywords: Long hauler, Long COVID, COVID Long term, Síntomas Persistentes de COVID, Síntomas Post-Agudos, COVID de Larga Duración, COVID-19 Persistente, COVID Post-aguda, COVID Subaguda, COVID-19 Crónica, Síndrome Post-COVID, Fatiga Post-viral, Ivermectina.
Communities
Communities with gateway
OpenAIRE Connect image
Download fromView all 3 versions
Open Access
ZENODO
Preprint . 2020
Provider: ZENODO
null
ResearchGate
Other literature type . 2020
Provider: Datacite
null
ResearchGate
Other literature type . 2020
Provider: Datacite
Any information missing or wrong?Report an Issue